An investor asked on the investor interaction platform: Hello, secretary, why is the gross profit margin of the company’s products up to 90% and the net profit only 15.8%? Looking at the statement, the operating expenses will be 1.47 billion in 9 months. Where did you pay? Is there financial fraud? Kweichow Moutai Co.Ltd(600519) gross profit margin 91%, net profit 53%.
Beijing Aosaikang Pharmaceutical Co.Ltd(002755) (002755. SZ) said on the investor interaction platform on January 17 that the company mainly focuses on injection products, the clinical path is complex, and the operating expenses are not different from those of similar companies. Corporate governance strictly abides by relevant laws and regulations, and there is no financial fraud.
